Page 231 - PROGRAMME2018
P. 231

 POSTER VIEWING SESSION
Endometriosis, endometrium and fallopian tube, and benign disorders of the endometrium and fallopian tube
P-239 Preimplantation genetic screening in endometriosis and non-endometriosis patients in a single institution
S.J. Chon1, B.H. Yun2, Y.S. Jung3, Y.J. Cho1, S.Y. Jung1
1Gil Hospital, Obstetrics and Gynecology, Incheon-si, Korea- South 2Severance Hospital, Obstetrics and Gynecology, Seoul, Korea- South 3Wonju Severance Hospital, Obstetrics and Gynecology, Wonju, Korea- South
P-240 Factors affect the outcome of IVF and the recurrence of the endometrial disease of patients with atypical endometrial hyperplasia (AEH) and early well-differentiated endometrial adenocarcinoma(EC)
H. Li1, X. Song1, R. Li1, J. Qiao1
1Peking University Third Hospital, Department of Obstetrics and Gynecology- Reproductive Medical Center, Beijing, China
P-241 Chronic endometritis: Prevalence using hysteroscopy and CD138 immunohistochemistry and impact on reproductive outcome in patients with previous IVF/ICSI failure
S. Anis Hebisha1, N. Mashaly2, N. Elbadawy3
1Faculty of Medicine-Alexandria University, OBGYN, Alexandria, Egypt 2Faculty of Medicine-Alexandria University, Pathology, Alexandria, Egypt 3Research Institute- Alexandria University, Pathology, Alexandria, Egypt
P-242 Naturally occurring endometriosis in the cynomolgus macaque: effects of analgesics on pain-related behavior and brain activation
I. Hayashi5, A. Matsuda2, T. Natsume3, M. Yano2, S. Ogawa4, Y. Awaga4, A. Hama1, H. Takamatsu4 1Hamamatsu Pharma Research- Inc., Research Plannning, Hamamatsu, Japan
2Hamamatsu Pharma Research- Inc., Animal Care, Hamamatsu, Japan
3Hamamatsu Pharma Research- Inc., Contract Research, Hamamatsu, Japan
4Hamamatsu Pharma Research- Inc., Pharmacology, Hamamatsu, Japan 5Hamamatsu Pharma Research USA- Inc., Business Development, Hamamatsu, Japan
P-243 Antifertility effectiveness of a novel copper-containing intrauterine device material and its influence on the endometrial environment in rats
S. Hu1, W. Xia1, C. Zhu1, Q. Yu2
1Family Planning Research Institute- Tongji Medical College, Huazhong University of Science and Technology, Wuhan- Hubei, China
2Reproductive Medicine Center- Tongji Medical College-Tongji Hospital, Huazhong University of Science and Technology, Wuhan- Hubei, China
                FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018 231
   POSTERS













































































   229   230   231   232   233